| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/30/2006 | WO2006032245A1 Pharmaceutical active ingredient against hiv - syndrome |
| 03/30/2006 | WO2006017353A3 Treatment of viral infections |
| 03/30/2006 | WO2005123137A3 Lyophilized pharmaceutical composition comprising moxifloxacin hydrochloride |
| 03/30/2006 | WO2005111065A3 Epitope-enhancement of a human cd4 hiv epitope |
| 03/30/2006 | WO2005082331A3 Extended release tablets of clarithromycin |
| 03/30/2006 | WO2003014294A3 Tacis and br3 polypeptides and uses thereof |
| 03/30/2006 | US20060069265 Reacting cysteine (or a salt or an ester) and an aryl carboxylic acid to form a thiazoline ring; stereospecifically alkylating the thiazoline ring, and hydrolyzing the thiazoline ring to obtain a 2-alkylcysteine; chelation |
| 03/30/2006 | US20060069153 Administering dithiocarbamate compound having the structural formula R1R2NCS2H for therapy of infection by an RNA virus which attacks the respiratory tract and causes disease selected from picornavirus, ortho-myxovirus, rhinovirus, enterovirus, coxsackie virus, aphthovirus, or paramyxovirus |
| 03/30/2006 | US20060069131 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 03/30/2006 | US20060069129 Chemokine receptor binding heterocyclic compounds |
| 03/30/2006 | US20060069126 Pharmaceutically active isoindoline derivatives |
| 03/30/2006 | US20060069112 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein |
| 03/30/2006 | US20060069108 Use of (R)-penciclovir triphosphate for the manufacture of a medicament for the treatment of viral diseases |
| 03/30/2006 | US20060069091 E.g., 2-[2-carboxypropyl]-5-hydroxy-1,2-oxazin-3-one, more potent than desacetoxycephalosporin G; bactericides reacting irreversibly with the active site serine residue of the enzyme; enzyme inhibitors; mimetics; isocephalosporins; monocyclic beta-lactam antibiotics; antibiotic resistance |
| 03/30/2006 | US20060069084 Methods of inhibiting kinases |
| 03/30/2006 | US20060069057 Medicaments containing xenogeneic oligo- and/or polyribonucleotides |
| 03/30/2006 | US20060069046 Green tea extract ; for use in foods and supplements |
| 03/30/2006 | US20060068389 Methods and compositions for inhibiting hiv replication |
| 03/30/2006 | US20060067982 Encasing a core made of a siloxane-based elastomer containing dexamethasone, betamethasone, beclomethasone, and/or budesonide with a membrane made of the same or a different elastomer; and shaping the device into a shape suitable for implantation into the ear or nose |
| 03/30/2006 | US20060067966 Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
| 03/30/2006 | US20060067948 Viral vectors |
| 03/30/2006 | US20060067946 Method of treatment using ligand-immunogen conjugates |
| 03/30/2006 | US20060067932 Antagonists specific for denatured collagen and methods of using same |
| 03/30/2006 | US20060067921 Probiotic bacterium: lactobacillus fermentum |
| 03/30/2006 | US20060067914 Immortalized natural killer cell line |
| 03/30/2006 | DE102004046024A1 Antibiotikum und Verfahren zur Herstellung Antibiotic and methods for preparing |
| 03/30/2006 | DE102004044556A1 Use of kinase inhibitors (e.g. serine/threonine kinase inhibitors) for treating viral infections caused by human cytomegalo virus |
| 03/30/2006 | DE102004043945A1 Mund-, Zahn- und Zahnprotesenpflegemittel enthaltend die Plaquebildung inhibierende Substanzen Oral, dental and Zahnprotesenpflegemittel containing plaque formation inhibiting substances |
| 03/30/2006 | CA2584290A1 Staphylococcal immunogenic compositions |
| 03/30/2006 | CA2580137A1 Immunogenic composition |
| 03/30/2006 | CA2580103A1 Immunogenic composition for use in vaccination against staphylococcei |
| 03/30/2006 | CA2579907A1 Carbo- and hetero-cyclic antibiotics and use thereof |
| 03/30/2006 | CA2579787A1 Novel vaccine for veterinary and human medicine prophylaxis and therapy |
| 03/30/2006 | CA2578428A1 Ring-closing metathesis process in supercritical fluid |
| 03/30/2006 | CA2577831A1 Process for preparing macrocyclic hcv protease inhibitors |
| 03/30/2006 | CA2577519A1 Multiple rna polymerase iii promoter expression constructs |
| 03/30/2006 | CA2577413A1 Carbazole and cyclopentaindole derivatives to treat infection with hepatitis c virus |
| 03/29/2006 | EP1640898A1 Medical care self-cell delivery support system, medical care self-cell delivery support financial system, and their methods |
| 03/29/2006 | EP1640383A1 Disialoundecasaccharide chain asparagine/fatty acid amide and medical drug containing the same |
| 03/29/2006 | EP1640371A1 Flavanone compound and uses thereof |
| 03/29/2006 | EP1640018A1 Combinational therapy for treating cancer |
| 03/29/2006 | EP1640011A1 Novel complexes of fatty acid esters of polyhydroxylalkanes and pyridine carboxy derivates |
| 03/29/2006 | EP1640003A2 Compositions comprising a Cyclooxygenase-2 Inhibitor and a Leukotriene B4 receptor antagonist |
| 03/29/2006 | EP1639994A2 Topical composition comprising N-acetylaldosamines or N-acetylamino acids |
| 03/29/2006 | EP1639971A1 Skin protecting compositions |
| 03/29/2006 | EP1639029A2 Biodegradable poly(beta-amino esters) and uses thereof |
| 03/29/2006 | EP1638993A1 Immunomodulating compositions, uses therefor and processes for their production |
| 03/29/2006 | EP1638972A2 Novel crystalline forms of valacyclovir hydrochloride |
| 03/29/2006 | EP1638938A2 Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
| 03/29/2006 | EP1638603A1 Methods for the prevention and treatment of diseases caused by an inflammatory response mediated by endogenous substance p by using anti-substance p antibodies |
| 03/29/2006 | EP1638599A1 Vaccine composition for vaccinating dogs against canine infectious respiratory disease (cird) |
| 03/29/2006 | EP1638597A2 Polyanionic polymer adjuvants for haemophilus influenza b saccharide vaccines |
| 03/29/2006 | EP1638584A1 Use of a compound for inhibiting viral particles |
| 03/29/2006 | EP1638578A2 Hydrolytically-resistant boron-containing therapeutics and methods of use |
| 03/29/2006 | EP1638555A1 Substituted 5-membered ring compounds and their use |
| 03/29/2006 | EP1638547A1 Composition for preventing urinary system infections |
| 03/29/2006 | EP1638506A2 Topical antiviral therapeutic and prophylactic treatment of adenoviruses and their associated diseases |
| 03/29/2006 | EP1539745B1 N-aryl-2-oxazolidinones and their derivatives |
| 03/29/2006 | EP1476190B1 Amino-substituted hypocrellins for use as sonosensitizers |
| 03/29/2006 | EP1385496A4 Use of compositions for treating rosacea |
| 03/29/2006 | EP1305402B1 Lipo-viro-particle complexes, preparation method and uses |
| 03/29/2006 | EP1210132A4 Herb medicine composition to be contained in sanitary materials for infants |
| 03/29/2006 | EP1210113B1 Combined vaccine compositions |
| 03/29/2006 | EP1200395B1 Urea derivatives as inhibitors of ccr-3 receptor |
| 03/29/2006 | EP1124565B1 Azido derivatives of beta-l-2'-deoxy-nucleosides for the treatment of hiv infection |
| 03/29/2006 | EP1100468B1 Microparticles with adsorbent surfaces, methods of making same, and uses thereof |
| 03/29/2006 | EP1077715B1 Use of rosmarinic acid and derivatives thereof as an immunosuppressant or an inhibitor of sh2-mediated process |
| 03/29/2006 | EP1060180B1 Process for synthesizing carbapenem antibiotics |
| 03/29/2006 | EP1036090B1 Echinocandin derivatives, preparation method and application as anti-fungal agents |
| 03/29/2006 | EP1012331B1 Compositions and methods for the delivery of oligonucleotides via the alimentary canal |
| 03/29/2006 | EP1005363B1 Recombinant dimeric envelope vaccine against flaviviral infection |
| 03/29/2006 | EP0990031B1 Tumor necrosis factor receptor 5 |
| 03/29/2006 | EP0977555B1 Pharmaceutical preparations and methods for their regional administration |
| 03/29/2006 | EP0973518B1 Semi-synthetic studies toward didemnin analogues |
| 03/29/2006 | EP0956343B1 Recombinant swinepox virus |
| 03/29/2006 | EP0833925B1 Diagnostic test for equine arteritis virus mediated disease |
| 03/29/2006 | EP0751709B2 Use of bcl-2 for the manufacture of medicaments for the therapeutic treatment and prevention of diseases |
| 03/29/2006 | EP0717777B1 Salmonella vaccines |
| 03/29/2006 | CN1754100A A screening method |
| 03/29/2006 | CN1753996A The gene cluster involved in safracin biosynthesis and its uses for genetic engineering |
| 03/29/2006 | CN1753901A Macrolide solvates |
| 03/29/2006 | CN1753900A Inhibitors |
| 03/29/2006 | CN1753896A Novel compounds and uses thereof |
| 03/29/2006 | CN1753892A Tetrahydro-4h-pyrido[1,2-a]pyrimidines and related compounds useful as HIV integrase inhibitors |
| 03/29/2006 | CN1753888A Hydroxymethyl substituted dihydroisoxazole derivatives useful as antibiotic agents |
| 03/29/2006 | CN1753875A Growth promotion method |
| 03/29/2006 | CN1753687A Use of cpg oligonucleotides in the treatment of hepatitis c virus infection |
| 03/29/2006 | CN1752106A Method of manufacturing human antibody possessing bioreceptor synergist, antagonist and/or inverse synergist |
| 03/29/2006 | CN1752099A SARS-S antigen polypeptide capable of inducing producing specificity immune response |
| 03/29/2006 | CN1751741A Nano carbon tube infusion agent, its prepn. method and application in treating cancer, cardiovascular disease and infectious disease |
| 03/29/2006 | CN1751735A Traditional Chinese medicine-Liganlong oral liquor for treating hepatopathy and its prepn. method |
| 03/29/2006 | CN1751733A Soft capsule of traditional Chinese medicine Angong Niuhuang and its prepn. method |
| 03/29/2006 | CN1751721A Traditional Chinese medicine soft capsule for ventilating regulating lung, and its prepn. method |
| 03/29/2006 | CN1751715A Method for testing and controlling quality of medicine schisantherin |
| 03/29/2006 | CN1751714A Novel administration route for compound injection contg. dandelion and its prepn. method |
| 03/29/2006 | CN1751713A Recipe of |
| 03/29/2006 | CN1751708A Method for extracting active component of radix scutellariae |
| 03/29/2006 | CN1751702A Specific prescription for treating ringworm nails and hand tinea |
| 03/29/2006 | CN1247775C Attenuated cattle viral diarrhoea virus |
| 03/29/2006 | CN1247595C Anhydrous crystal of beta-lactam compound and method for producing the same |